A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation. - Morandi F; Della Lastra M; Tripodi G; Sabatini F; Cocco C; Risso M; Gramignoli R; Zara F; Airoldi I (Cell transplantation, 2026)